Tallac Therapeutics, Inc.
Biotechnology company · Burlingame, California, United States
Tallac Therapeutics, Inc. is a biotechnology company headquartered in Burlingame, California, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $62 million sold in a notice filed in 2021.
Tallac Therapeutics at a glance
What does Tallac Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $61.6 million sold (2021).
Frequently asked questions about Tallac Therapeutics
Where is Tallac Therapeutics headquartered?
Tallac Therapeutics, Inc. is headquartered in Burlingame, California, United States.
What does Tallac Therapeutics do?
Tallac Therapeutics, Inc. is a biotechnology company.
When was Tallac Therapeutics founded?
The earliest incorporation on record for Tallac Therapeutics, Inc. is in 2018, according to public company registers.
Similar companies
- Inflammatix, Inc.Burlingame, California, United States
- Hinge Bio, Inc.Burlingame, California, United States
- Magnus Medical, Inc.Burlingame, California, United States
- Optofluidics, Inc.Burlingame, California, United States
- Afasci, Inc.Burlingame, California, United States
- Nextrast, IncBurlingame, California, United States
- Attralus, Inc.Burlingame, California, United States
- Biodesy LLCBurlingame, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences